ライフサイエンスコーパス: vitronectin receptor

1 ct was observed on the alphaVbeta3 integrin (vitronectin receptor).

2 that MMP-2 did not interact with the murine vitronectin receptor.

3 same pharmacological profile as the platelet vitronectin receptor.

4 Abs that recognize the murine alpha v beta 3 vitronectin receptor.

5 ibition of the binding of vitronectin to the vitronectin receptor.

6 , indicating the involvement of integrins as vitronectin receptors.

7 23c6+ cells (an antibody that recognizes the vitronectin receptor), 87.5% of which coexpressed the ca

8 In summary, vitronectin receptor activation is a necessary component

9 The vitronectin receptor alpha(v)beta(3) integrin is of key

10 We established that whereas the vitronectin receptor alpha(v)beta(3) remains within foca

11 nerated compounds with high affinity for the vitronectin receptor alpha(v)beta(3).

12 The vitronectin receptor (alpha v beta 3) is a member of the

13 block the lytic activity through either the vitronectin receptor (alpha(V)beta(3) integrin) or CD44.

14 The role of the vitronectin receptor (alpha(v)beta(3)-integrin) as a tum

15 Small vessels persistently expressed the vitronectin receptor, alpha v beta 3, a marker of angiog

16 ersus the most closely related integrin, the vitronectin receptor, alpha v beta 3.

17 tronectin, does not associate with the major vitronectin receptor, alpha(v)beta(3) integrin, and does

18 cting the expression and localization of the vitronectin receptors, alpha(v)beta(3) and alpha(v)beta(

19 Integrins containing alpha-V (vitronectin receptor), alpha5 (fibronectin receptor), an

20 ecules for integrin alphaIIbbeta3 versus the vitronectin receptor alphaVbeta3.

21 IIb-IIIa (GPIIb-IIIa; alphaIIbbeta3) and the vitronectin receptor alphavbeta3.

22 s of phenylbutyrate-based antagonists of the vitronectin receptors alphavbeta3 and alphavbeta5 signif

23 well as cyclic RGD peptides that bind to the vitronectin receptors alphavbeta3 and alphavbeta5 signif

24 The vitronectin receptor (alphavbeta3) mediates several biol

25 In this system, CD9 did not bind to vitronectin receptor (alphavbeta3) suggesting that CD9/a

26 Among the two vitronectin receptors, alphavbeta3 and alphavbeta5 integ

27 own about kindlin regulation of the related "vitronectin receptor," alphaVbeta3.

28 c-Cbl lies downstream of the vitronectin receptor and forms a complex with c-Src and

29 hatase, and expression of the calcitonin and vitronectin receptors and of pp60c-src tyrosine kinase.

30 recognizes the alpha V beta 3 integrin (the vitronectin receptor), as did several mononuclear cells

31 re able to extend focal complex formation to vitronectin receptors by the removal of c-Src.

32 tase-positive cell formation, expressions of vitronectin receptors, c-src and calcitonin receptors, a

33 These include alpha V beta 3 (CD51/CD61, vitronectin receptor), CD36 (thrombospondin receptor), m

34 s less than 15% of normal and alpha v beta 3 vitronectin receptor expression was 15% to 19% of normal

35 g a possible function for the alpha v beta 3 vitronectin receptor in T cell development.

36 s and sugars, implicating involvement of the vitronectin receptor in this case.

37 g antibody to the alpha v beta 5 integrin (a vitronectin receptor) inhibited migration of MCF-7 cells

38 peptide, and mAbs to phagocyte alpha(v)beta3 vitronectin receptor integrin and "bridging" thrombospon

39 Both vitronectin receptor (integrin alpha(v)beta3) and tissue

40 The vitronectin receptor (integrin alphavbeta3) and TF have

41 nizes the beta chain of the endothelial cell vitronectin receptor (integrin alphavbeta3), or fibrinog

42 The vitronectin receptor is a member of the integrin family

43 The integrin alphavbeta5 vitronectin receptor is expressed on the apical membrane

44 The alpha v beta 3 vitronectin receptor is responsible for binding endothel

45 roteolysis by examining the direct effect of vitronectin receptor ligation on matrix metalloproteinas

46 ons with a functional actin cytoskeleton and vitronectin receptor ligation.

47 Therefore, the vitronectin receptor might not be an appropriate therape

48 nt BAEC monolayers with a blocking type anti-vitronectin receptor monoclonal antibody had similar inh

49 demonstrated that FAK tended to cluster with vitronectin receptor near the abluminal side of the shea

50 sion of the beta3 subunit of the alphavbeta3 vitronectin receptor on melanoma cells is associated wit

51 ntibodies and peptides that inhibit integrin vitronectin receptors on phagocytosis of ROS by RPE were

52 sing integrin alphavbeta3 (also known as the vitronectin receptor) or alphaIIbbeta3 (platelet glycopr

53 Furthermore, Tax was expressed in vitronectin receptor-positive mononuclear precursors as

54 the inhibition of vitronectin binding to the vitronectin receptor, showing the high in vitro receptor

55 in polymerization) or cyclo(RGDfV) (to block vitronectin receptors) significantly prevented neuronal

56 chain reaction was used to identify integrin vitronectin receptor subunit mRNAs expressed in embryoni

57 Spatial expression patterns of vitronectin receptor subunits at early times of developm

58 rating cells increase expression of both the vitronectin receptor (VNR) integrins and plasminogen act

59 llular adhesion molecule-1 (ICAM-1), and the vitronectin receptor (VnR).

60 ceptors for von Willebrand factor (vWF), the vitronectin receptor (VNR, alpha(v)beta3), which recogni

61 osphatidylserine (PS)-exposing cells and the vitronectin receptor (VR) on phagocytes.

62 pidermal growth factor-8, and its microglial vitronectin receptor was sufficient to rescue up to 90%